Oppenheimer Reiterates Buy as Red Hat (RHT) Reports Solid 2Q Results

Go back to Oppenheimer Reiterates Buy as Red Hat (RHT) Reports Solid 2Q Results

Red Hat (RHT): Impressive Quarter - UBS

September 22, 2016 9:28 AM EDT

UBS analyst, Brent Thill, reiterated his Buy rating on shares of Red Hat (NYSE: RHT) and raised his price target to $90 from $85 after posting 20% y/y growth in both subscription revenue (highest Q2 number in 5 yrs) and billings (beat by $16M, but off... More

Pre-Open Stock Movers 09/22: (WCIC) (AVXL) (NVAX) Higher; (MLHR) (JBL) (CPK) Lower (more...)

September 22, 2016 9:22 AM EDT

Today's Pre-Open Stock Movers

WCI Communities, Inc. (NYSE: WCIC) 36.3% HIGHER; Lennar Corporation (NYSE: LEN) and WCI... More

BMO Capital Raises Price Target on Red Hat (RHT) Following 2Q

September 22, 2016 8:45 AM EDT

BMO Capital reiterated an Outperform rating on Red Hat (NYSE: RHT), and raised the price target to $89.00 (from $85.00), following the company's 2Q earnings report. RHT delivered good billings at $573 million vs. estimates of $556 million. Total revenues were $600 million vs. the consensus of $590 million.... More

Red Hat (RHT): Raising PT After A Breakout Quarter - Drexel Hamilton

September 22, 2016 8:17 AM EDT

Drexel Hamilton analyst, Brian White, reiterated his Buy rating on shares of Red Hat (NYSE: RHT) and raised his price target to $110.00 (from $105.00) after determining that yesterday's report represents a breakout for the stock.

Despite a healthy performance this year, Red... More

Mizuho Securities Reiterates Buy on Red Hat (RHT) Following 2Q Report

September 22, 2016 7:41 AM EDT

Mizuho Securities reiterated a Buy rating and $88.00 price target on Red Hat (NYSE: RHT) following the company's 2Q earnings report. RHT reported total revenue of $600mm vs. consensus of $590mm with upside coming in from the subscription line as the company benefited from FX... More

William Blair Reiterates Red Hat (RHT) at 'Outperform'; Linux Bolsters Beat-and-Raise Quarter

September 22, 2016 7:29 AM EDT

William Blair affirms Red Hat (NYSE: RHT) with an Outperform rating following Q2 results issued Wednesday night.

The firm summarized: Red Hat turned in a solid fiscal second quarter, topping consensus by roughly $10 million on revenue and $0.01 on non-GAAP EPS, and guiding fiscal third quarter and full year 2017 above consensus on revenue and EPS. The story in the August quarter was a reacceleration in core... More

After-Hours Stock Movers 09/21: (OCRX) (NVAX) (RHT) Higher; (MLHR) (JBL) (ALOG) Lower (more...)

September 21, 2016 5:41 PM EDT

Today's After-Hours Movers

Ocera Therapeutics, Inc. (NASDAQ: OCRX) 24.2% HIGHER; announced completion of enrollment in STOP-ALF, a Phase 2a clinical trial to evaluate the Safety and Tolerability of Ornithine Phenylacetate in patients with Acute Liver Failure. The study was conducted by the Acute Liver Failure Study Group, an NIH-sponsored network of university tertiary care liver transplant sites, with support and supply of study medication from Ocera.

Herman Miller (NASDAQ: MLHR) 11% LOWER; reported Q1 EPS of $0.60, $0.02 worse than the analyst... More

Red Hat (RHT) Tops Q2 EPS by 1c

September 21, 2016 4:16 PM EDT

Red Hat (NYSE: RHT) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $600 million versus the consensus estimate of $593.34 million.

Subscription revenue from Infrastructure-related offerings for the quarter was $427 million, an increase of 18% in U.S.... More

Red Hat (RHT) calls more active than puts into Q2 results and outlook

September 21, 2016 3:26 PM EDT

Red Hat (NYSE: RHT) September weekly call option implied volatility is at 29, October is at 29; compared to its 52-week range of 21 to 45 into the expected release of Q2 results today after the market close. Call put ratio is 1.8 calls to 1 put.

... More

Streetinsider.com's Hot Lunchtime Reads 9/21: (LL) (RHT) (CUR) (TSLA)

September 21, 2016 12:13 PM EDT

The following is a list of notable articles to help get you through the lunch hour:Maxim Group Downgrades Mast Therapeutics (MSTX) to Hold Following Vepoloxamer Phase 3 Miss ->... More

Mizuho Securities Reiterates Buy Ahead of Red Hat's (RHT) 2Q Report

September 21, 2016 11:51 AM EDT

Mizuho Securities reiterated a Buy rating and $88.00 price target on Red Hat (NYSE: RHT) ahead of the company's 2Q earnings report. Mizuho expects management to remain conservative with guidance and reiterate its current full-year revenue and EPS forecast of $2.380-2.420bn and $2.19-2.23,... More

Trading Radar for 9/21: General Mills (GIS), CarMax (KMX), Red Hat (RHT), Jabil (JBL), Analogic (ALOG) Report

September 20, 2016 2:08 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

CarMax (NYSE: KMX) - consensus EPS $0.88
General Mills (NYSE: GIS) - consensus EPS... More